Why have aesthetic medicine in Brazil: a guide for expats comparing USA, Europe, and Brazilian options

Brazil has one of the most active and internationally recognised aesthetic medicine ecosystems in the world. Understanding why — and where that recognition has limits — is the starting point for any international patient making an informed decision about where to receive care.

The institutional foundation is real. The Brazilian Society of Plastic Surgery (SBCP — Sociedade Brasileira de Cirurgia Plástica) is one of the oldest and most influential professional bodies in global plastic and reconstructive surgery. Brazil consistently ranks among the top three countries worldwide for total aesthetic procedures performed, a statistic tracked annually by the International Society of Aesthetic Plastic Surgery (ISAPS). The legacy of Professor Ivo Pitanguy — who trained generations of surgeons at the Pontifical Catholic University of Rio de Janeiro and whose work on body contouring and facial anatomy is cited in global surgical literature — established a culture of high-volume, high-stakes surgical training that has since extended into the minimally invasive domain.

Regulatory oversight of aesthetic products in Brazil is managed by ANVISA (Agência Nacional de Vigilância Sanitária), the Brazilian health surveillance agency. ANVISA operates under a framework structurally comparable to the FDA in the United States and the EMA in Europe: it reviews clinical safety and efficacy data submitted by manufacturers before granting market authorisation. The major injectable products used in Brazilian aesthetic practice — hyaluronic acid fillers from the Juvéderm and Restylane families, botulinum toxin preparations (Botox, Dysport, Xeomin), biostimulators (Sculptra, Radiesse, HarmonyCa), and energy-based devices (Morpheus8, Fotona, Ultraformer) — are the same globally distributed products supplied by Allergan Aesthetics, Galderma, Merz Aesthetics, and InMode. ANVISA-registered products are not reformulated for the Brazilian market; they are the same manufacturers, same batch testing standards, same cold-chain requirements.

The honest caveat — and it matters — is that Brazil's size and regulatory infrastructure mean that the standard of practice varies considerably across the country and across practitioners. World-class clinical care coexists with a long tail of undertrained practitioners, substandard product sourcing, and inadequate patient selection. This is not unique to Brazil: the same heterogeneity exists in the United States and across Europe. The relevant question is not "is Brazil safe?" in the abstract — it is "how do I identify a qualified practitioner?"

For international patients in Brasília specifically, the context is differentiated from São Paulo or Rio de Janeiro. The city's diplomatic infrastructure creates a resident population accustomed to international standards of care, and a subset of physicians who trained abroad or maintain international affiliations have oriented their practice accordingly. The competitive pressure to provide bilingual, internationally benchmarked care in Brasília is real and measurable.

Aesthetic medicine in Brazil is a sound choice for international patients who select carefully, plan the logistical realities honestly, and maintain realistic expectations about follow-up care continuity. It is not a universally better choice than care in the USA or Europe — it is a competitive option in specific circumstances.

Decision framework

Brazil is well-suited for patients who:

• Are resident in or regularly visiting Brasília (diplomatic posting, extended work assignment, family ties) and can plan follow-up appointments as part of their normal schedule
• Are considering elective single-session procedures where continuity of care is less critical — neuromodulators, single-filler sessions, or consultation-and-treat visits
• Have researched practitioners rigorously in advance and have identified a specific physician whose training, clinical output, and language capability meet their requirements
• Understand that a multi-session protocol (biostimulators, energy-based devices, regenerative injectables) requires multiple visits and that travel costs and logistics must be factored into the true cost comparison
• Are seeking a second clinical opinion on a treatment plan proposed elsewhere

Brazil is less suited for patients who:

• Require a complex multi-session protocol with closely spaced intervals and cannot commit to being in Brasília for the duration
• Have had complications from prior treatments that require specialist management — these patients need continuity with a physician who has their full clinical history
• Are prioritising proximity to home for follow-up above cost savings

Verification steps before choosing a physician in Brazil

The following steps apply regardless of country — they are the standard due diligence for selecting any aesthetic medicine practitioner:

1. Confirm CFM registration. Every licensed physician in Brazil has a CFM registration number, publicly searchable on the CFM website. Verify that the physician is registered and in good standing.
2. Check SBCP membership for surgical procedures. For any surgical procedure, SBCP membership provides a meaningful training credential.
3. Ask about product sourcing explicitly. A physician confident in their product supply chain will confirm the manufacturer, lot documentation practice, and cold-chain handling without hesitation. Evasion on this question is a red flag.
4. Assess clinical consultation quality. A qualified practitioner conducts a structured clinical assessment before proposing any treatment — including a full medical history, anatomical assessment with facial photography, and a clearly explained treatment rationale.
5. Review before-and-after documentation critically. Consistent documentation of anonymised patients across a range of anatomies and treatment types reflects clinical experience.
6. Evaluate English-language capability directly. For international patients, the ability to communicate clinical history, concerns, and informed consent in your language is a clinical safety issue, not merely a convenience.

International follow-up care

Patients returning home after treatment should receive written documentation of the products used (manufacturer, product name, concentration or formulation, volume per site), the injection technique, and the follow-up schedule. This documentation allows a treating physician in any country to manage continuity of care or address any delayed complication. Request this documentation as a standard at any clinic — the practice of providing it is itself a quality signal.

Updated 22 May 2026